Lucas McKay, J.
Goldstein, Felicia C.
Sommerfeld, Barbara
Bernhard, Douglas
Perez Parra, Sahyli
Factor, Stewart A.
Funding for this research was provided by:
Curtis Family Fund Sartain Lanier Family Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K25 HD086276)
National Parkinson Foundation
Article History
Received: 22 July 2019
Accepted: 31 October 2019
First Online: 22 November 2019
Competing interests
: J.L.M. has no competing interests, F.C.G. has no competing interests, B.S. has no competing interests, D.B. has no competing interests, S.P.P. has no competing interests, S.A.F. has the following competing interests: Honoraria: Lundbeck, Teva, Sunovion, Biogen, Acadia, Neuroderm, Acorda, CereSpire. Grants: Ipsen, Medtronics, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, Lilly, CHDI Foundation, Michael J. Fox Foundation, NIH, Royalties: Demos, Blackwell Futura for textbooks, Uptodate, Other Bracket Global LLC, CNS Ratings LLC.